Skip to main content
Fig. 3 | BMC Endocrine Disorders

Fig. 3

From: Low-dose spironolactone ameliorates adipose tissue inflammation and apoptosis in letrozole-induced PCOS rat model

Fig. 3

Effects of low-dose SPL on adipose MDA (a) GSH (b) and G6PD (c) in experimentally induced PCOS rat model. Data are expressed as S.D, n = 6. (*p < 0.05 vs. CTR, #p < 0.05 vs. LET). Control (CTR), Letrozole (LET), Spironolactone (SPL), Malondialdehyde (MDA), Reduced glutathione (GSH), Glucose-6 phosphate dehydrogenase (G6PD)

Back to article page